A thiophen-thiooxorhodamine conjugate fluorescent probe for mercury in aqueous

合集下载

常见细菌真菌中英文对照(史上最全,纯手工整理)

常见细菌真菌中英文对照(史上最全,纯手工整理)
Bruker 可鉴定菌属/菌种/亚种名 Kluyvera georgiana Rhodococcus zopfii Bifidobacterium minimum Bacillus drentensis Prevotella histicola Xanthobacter autotrophicus Chromobacterium violaceum Clostridium isatidis Streptomyces violaceoruber B263 UFL Rhodococcus rhodochrous Microbacterium testaceum Staphylococcus hyicus Streptococcus suis II Streptococcus suis I Streptococcus suis Salmonella sp (enterica st Diarizonae) Salmonella sp (choleraesuis) Salmonella choleraesuis Erysipelothrix rhusiopathiae Actinobacillus suis Mycoplasma hyorhinis Grimontia hollisae Geotrichum penicillatum Candida rugosa Candida rugosa var rugosa CBS 613T CBS Pseudomonas corrugata Fusobacterium naviforme Corynebacterium diphtheriae belfanti Corynebacterium diphtheriae gravis Terrabacter tumescens Pseudacidovorax intermedius Yersinia intermedia Aeromonas media Prevotella intermedia Staphylococcus intermedius Streptococcus intermadius Streptococcus intermedius Kluyvera intermedia Candida intermedia Enterobacter intermedius

拉帕替尼结构式

拉帕替尼结构式

拉帕替尼结构式拉帕替尼结构式(Lapatinib structure)是一种用于治疗乳腺癌和胃癌的药物。

它属于一类叫做酪氨酸激酶抑制剂(tyrosine kinase inhibitors)的药物,通过抑制肿瘤细胞中的酪氨酸激酶的活性,从而阻断肿瘤细胞的生长和扩散。

拉帕替尼的化学结构拉帕替尼的化学名称是4-([3-chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino)-6-[5-[[(2-methanesulfonylethyl)amino]methyl]-2-furyl]quinazoline。

它的分子式为C29H26ClFN4O4S,分子量为581.06克/摩尔。

拉帕替尼的结构式如下所示:在这个结构式中,可以看到拉帕替尼由一个苯环、一个吡唑环和一个喹唑啉环组成。

苯环上连接着一个氯原子和一个苯甲基氧基团。

吡唑环上连接着一个氟苯甲基氧基团。

喹唑啉环上连接着一个甲磺酸乙基胺基甲基氧基团。

这些不同的基团赋予了拉帕替尼独特的化学性质和药理活性。

拉帕替尼的药理作用拉帕替尼主要通过抑制肿瘤细胞中的表皮生长因子受体(EGFR)和人类表皮生长因子受体2(HER2)的激活来发挥作用。

EGFR和HER2是一种受体酪氨酸激酶,它们参与了许多细胞信号传导途径,包括细胞生长、分化和存活等。

过度激活的EGFR和HER2与肿瘤的发生和发展密切相关。

拉帕替尼通过与EGFR和HER2的ATP结合位点竞争结合,从而抑制其酪氨酸激酶活性。

这种抑制作用阻断了EGFR和HER2信号传导途径,抑制了肿瘤细胞的生长和扩散。

此外,拉帕替尼还能够通过抑制其他信号通路如PI3K/AKT/mTOR和MAPK等,进一步增强其抗肿瘤活性。

这些信号通路在肿瘤细胞的增殖、侵袭和转移中起到重要的作用。

拉帕替尼的临床应用拉帕替尼被广泛应用于乳腺癌和胃癌的治疗中。

在乳腺癌的治疗中,拉帕替尼通常与其他药物如氟尿嘧啶(5-fluorouracil)或紫杉醇(paclitaxel)等联合使用。

巨噬细胞极化在骨关节炎中的作用

巨噬细胞极化在骨关节炎中的作用

巨噬细胞极化在骨关节炎中的作用引言巨噬细胞是免疫系统中的重要成分,它在多种疾病中扮演着重要角色。

在骨关节炎中,巨噬细胞的极化状态对于疾病的发展和治疗至关重要。

本文将就巨噬细胞极化在骨关节炎中的作用展开深入探讨。

什么是巨噬细胞极化?巨噬细胞极化是指巨噬细胞在不同的微环境中表现出的不同形态和功能。

根据所接受的刺激和细胞因子的调节,巨噬细胞可以分化为两种主要类型,即经典型巨噬细胞(M1型)和曲张型巨噬细胞(M2型)。

经典型巨噬细胞(M1型)经典型巨噬细胞主要参与机体的炎症反应,并具有促炎作用。

当组织受损或感染时,巨噬细胞被激活并释放一系列的炎性细胞因子,如白细胞介素1β(IL-1β)、肿瘤坏死因子α(TNF-α)等。

这些细胞因子可以引起炎症细胞的浸润和活化,促进炎症反应的发生。

曲张型巨噬细胞(M2型)曲张型巨噬细胞主要参与组织修复和再生,并具有抗炎作用。

在抗炎反应中,曲张型巨噬细胞释放的细胞因子,如白细胞介素10(IL-10)、转化生长因子β(TGF-β)等,可以抑制炎症反应的发生,并促进伤口愈合。

巨噬细胞极化在骨关节炎中的作用巨噬细胞极化在骨关节炎的发展和进程中起着重要作用。

下面将从多个方面探讨巨噬细胞极化在骨关节炎中的具体作用。

1. 炎症反应的调节在骨关节炎中,巨噬细胞极化状态的改变可以调节病变区域的炎症反应。

炎症反应是骨关节炎的基本特征之一,巨噬细胞的极化能够促进或抑制炎症反应的发生。

M1型巨噬细胞的活化会释放大量炎性细胞因子,导致关节炎炎症的进一步加剧。

而M2型巨噬细胞的活化则可以抑制炎症细胞因子的产生,从而减轻炎症反应和相关疼痛。

2. 软骨退化的影响巨噬细胞极化状态的改变也会影响软骨的退化过程。

在骨关节炎中,软骨的退化是疾病的关键因素之一。

研究发现,M1型巨噬细胞的活化会产生一系列的骨吸收相关因子,如骨吸收细胞趋化因子和金属蛋白酶等,这些因子会促进软骨组织的逐渐退化。

相反,M2型巨噬细胞的活化则可以释放一些抗骨吸收因子,如骨抑制细胞趋化因子和组织抑制蛋白等,从而保护软骨组织的完整性。

奥替溴胺 化学结构式

奥替溴胺 化学结构式

奥替溴胺化学结构式
奥替溴胺化学结构式:CHBrN₂O₄
中文名称:奥替溴铵
中文别名:异雄酮.异雄酮;N,N-二乙基-N-甲基-2-[[4[[2-(辛基)苯甲酰]氨基]苯甲酰]氧基]乙烷铵溴化物;奥替溴胺
英文名称:Octylonium Bromide
奥替溴铵是一种抗毒蕈碱。

其化学式为N,N-二乙基-N-甲基-2-[[4[[2-(辛基)苯甲酰]氨基]苯甲酰]氧基]乙烷铵溴化物,是一种白色粉末,熔点为30-133 ℃。

临床上奥替溴铵是一种血小板活化因子的拮抗剂,可作为镇痛、抗炎、抑制子宫收缩和抗肿瘤剂。

奥替溴铵常用来解痉。

对于消化道平滑肌能够发挥强烈的解痉作用。

丁基甲氧基二苯甲酰基甲烷 别名

丁基甲氧基二苯甲酰基甲烷 别名

丁基甲氧基二苯甲酰基甲烷别名下载提示:该文档是本店铺精心编制而成的,希望大家下载后,能够帮助大家解决实际问题。

文档下载后可定制修改,请根据实际需要进行调整和使用,谢谢!本店铺为大家提供各种类型的实用资料,如教育随笔、日记赏析、句子摘抄、古诗大全、经典美文、话题作文、工作总结、词语解析、文案摘录、其他资料等等,想了解不同资料格式和写法,敬请关注!Download tips: This document is carefully compiled by this editor. I hope that after you download it, it can help you solve practical problems. The document can be customized and modified after downloading, please adjust and use it according to actual needs, thank you! In addition, this shop provides you with various types of practical materials, such as educational essays, diary appreciation, sentence excerpts, ancient poems, classic articles, topic composition, work summary, word parsing, copy excerpts, other materials and so on, want to know different data formats and writing methods, please pay attention!丁基甲氧基二苯甲酰基甲烷的别名及其应用1. 引言丁基甲氧基二苯甲酰基甲烷,是一种在化学领域备受关注的化合物,具有广泛的应用前景。

骨源性细胞因子在激素性股骨头坏死发生发展中的研究进展

骨源性细胞因子在激素性股骨头坏死发生发展中的研究进展

-综述•骨源性细胞因子在激素性股骨头坏死发生发展中的研究进展蒋捷,黄林科,胡峰△(广西医科大学第二附属医院,广西南宁530007)[摘要]股骨头坏死是骨外科常见的难治性疾病,其机制仍有待研究。

目前为止,医源性糖皮质激素是非创伤性股骨头坏死的主要原因。

激素的长期使用可导致股骨头骨细胞凋亡、血液循环障碍所致缺血缺氧,最终导致股骨头塌陷。

激素性股骨头坏死的发生发展与骨组织中细胞直接接触和其间接分泌的细胞因子调控相关。

本文综述了骨组织中成骨细胞分泌的核因子k B受体结合配体,骨保护素,骨碱性磷酸酶,骨细胞表达硬化素,破骨细胞分泌骨形态发生蛋白2等因子在SONFH的研究进展,骨源性细胞因子在SONFH中扮演重要作用。

[关键词]骨源性细胞因子;激素性股骨头坏死;临床分型;病理表现;综述[中图分类号]R681[文献标识码]A[文章编号]961-5639(2621)61-482-04doi:16.3969/E R w x961-5639.402000025Resevrch prggress of bone derived cytokines in developmenS of steaid induced osteynecrgsis of the femorai hecdJIANG Jia,HUANG Lia-Ue,HU Feng'(Department of OrtUopebic trauma,the Second Affiliated Hospital of Guanypi Medical Univer­sity?Nanning Citp,Guangpi Zhuang Autonomous Repiox530007,China)J Abstrach]Avascular necrosis of the femoral heah is a common refracton disease in ortUopebic shraeru/whose mechanism remains to be studied.So far,iatngenic glucocorncoids are the main cause of nox-EaumaWe necrosis of the femoral heah.Long term treatment of glucocorncoids leafs to osteocyte apoptosis of femoral heah,ischemia and hypoxia caused bp blood cinulaWon OisorUer,and eventuaLy leafs to coXapse of femoral heah.The occurrence and Oevelopment of steroid induced osteonecrosis of the femoral heah are related to the direct contact of cells in bone tissue and the repulaLox of cypdines secreted indirectly.We reviewed the research progress of Nuclear factor kaypa B receptor binding ligand,RANKL,OsPoproPpeEn;OPG and Bone aldaLne phosphamse;BAP secreted bp osteoblasts, eceeeohnt(SOST)peoducedbsoeheocsheeatdBotemoepeogetehncpeohent-2BMP-2eeceehedbsoeheoceaehenteheeondntducedoeheote-eeoeneoeheeeemoeaeeead0Botedeeneedeshoenteepeasatnmpoehatheoeenteheeondntdueedoeheoteeeoeneoeheeeemoeaeeead0J Key woras]Bone PeEved cytodines;2proid induced necrosis of the femoral heah;Clinical classification;PatUologicai manifestation;Reenew股骨头坏死(OWewecrwis of femoral heah,ONFH)是骨外科常见的难治性疾病,严重影响患者的生活质量。

四甲基铵巯基乙酸盐

四甲基铵巯基乙酸盐

四甲基铵巯基乙酸盐英文回答:Tetramethylammonium mercaptoacetate (TAMA) is a quaternary ammonium compound that is used as a precursor to other chemicals. It is also used as an antioxidant and a corrosion inhibitor. TAMA is a white or colorless solidthat is soluble in water and alcohol. It has a melting point of 120-122 °C and a boiling point of 270-272 °C.TAMA is synthesized by the reaction of tetramethylammonium hydroxide with 2-mercaptoacetic acid. The reaction is carried out in water at room temperature. The product is precipitated from the reaction mixture by the addition of a non-solvent such as diethyl ether.TAMA is used as a precursor to other chemicals, such as tetramethylammonium chloride and tetramethylammonium bromide. These chemicals are used in a variety of applications, including pharmaceuticals, dyes, anddetergents. TAMA is also used as an antioxidant and a corrosion inhibitor. It is added to fuels and lubricants to prevent oxidation and corrosion.中文回答:四甲基铵巯基乙酸盐。

天冬酰胺合成酶通过促进β-catenin核转位驱动胆管癌转移

天冬酰胺合成酶通过促进β-catenin核转位驱动胆管癌转移

天冬酰胺合成酶通过促进β-catenin 核转位驱动胆管癌转移*褚珍珍1,2, 周栩萱1,2, 刘力豪1, 张鲍欢3△, 姚楠1,2△(1暨南大学基础医学院病理生理学系,广东 广州 510632;2国家中医药管理局病理生理科研实验室,广东 广州510632;3暨南大学基础医学院形态学实验教学中心,广东 广州 510632)[摘要] 目的:检测天冬酰胺合成酶(ASNS )在胆管癌(CCA )中的表达情况,探讨ASNS 在CCA 转移中的作用及其机制。

方法:通过公共数据库分析各肿瘤组织中ASNS 的mRNA 表达;收集CCA 患者病理组织(n =27),构建硫代乙酰胺诱导的大鼠自发CCA 模型和左中位胆管结扎联合二乙基亚硝胺诱导的小鼠自发CCA 模型,通过免疫组化、Western blot 和免疫荧光法检测ASNS 蛋白表达。

采用CCK8、划痕和Transwell 实验检测ASNS 对人CCA 细胞HuCCT1和HCCC -9810增殖、迁移和侵袭的影响。

构建ASNS 稳定敲减的CCA 细胞株HuCCT1shNC 、HuCCT1shASNS 、HCCC -9810shNC 和HCCC -9810shASNS ,通过肝原位种植和尾静脉注射研究ASNS 对CCA 细胞肝内生长和肺转移的影响。

利用公共数据库富集与ASNS 相关的信号通路,并用免疫荧光和Western blot 验证相关分子机制。

结果:无论在人或动物CCA 组织中,ASNS 表达水平均高于癌旁组织(P <0.01)。

ASNS 以酶活性非依赖性方式促进CCA 细胞HuCCT1和HCCC -9810的增殖、迁移与侵袭。

生物信息学分析显示,β-catenin 在ASNS 高表达的CCA 组织中富集,ASNS 通过促进β-catenin 核转位,启动CCA 细胞上皮-间充质转化(EMT )。

β-catenin 抑制剂XAV -939可显著抑制CCA 细胞的侵袭与迁移。

世界卫生组织儿童标准处方集

世界卫生组织儿童标准处方集

WHO Model Formulary for ChildrenBased on the Second Model List of Essential Medicines for Children 2009世界卫生组织儿童标准处方集基于2009年儿童基本用药的第二个标准目录WHO Library Cataloguing-in-Publication Data:WHO model formulary for children 2010.Based on the second model list of essential medicines for children 2009.1.Essential drugs.2.Formularies.3.Pharmaceutical preparations.4.Child.5.Drug utilization. I.World Health Organization.ISBN 978 92 4 159932 0 (NLM classification: QV 55)世界卫生组织实验室出版数据目录:世界卫生组织儿童标准处方集基于2009年儿童基本用药的第二个标准处方集1.基本药物 2.处方一览表 3.药品制备 4儿童 5.药物ISBN 978 92 4 159932 0 (美国国立医学图书馆分类:QV55)World Health Organization 2010All rights reserved. Publications of the World Health Organization can be obtained fromWHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: ******************). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the aboveaddress(fax:+41227914806;e-mail:*******************).世界卫生组织2010版权所有。

邻甲氧基苯酚安全技术说明书

邻甲氧基苯酚安全技术说明书
第六部分:泄漏应急处理
应急处理:
迅速撤离泄漏污染区人员至安全区,并进行隔离,严格限制出入。切断火源。建议应急处理人员戴自给正压式呼吸器,穿防毒服。尽可能切断泄漏源。若是液体,防止流入下水道、排洪沟等限制性空间。小量泄漏:用砂土、蛭石或其它惰性材料吸收。大量泄漏:构筑围堤或挖坑收容。用泵转移至槽车或专用收集器内,回收或运至废物处理场所处置。若是固体,用洁净的铲子收集于干燥、洁净、有盖的容器中。若大量泄漏,收集回收或运至废物处理场所处置。
环境危害:
燃爆危险:
本品可燃,具强刺激性。
第四部分:急救措施
皮肤接触:
立即脱去污染的衣着,用大量流动清水冲洗至少15分钟。就医。
眼睛接触:
立即提起眼睑,用大量流动清水或生理盐水彻底冲洗至少15分钟。就医。
吸入:
脱离现场至空气新鲜处。就医。
食入:
用水漱口,给饮牛奶或蛋清。就医。
第五部分:消防措施
危险特性:
化学安全技术说明书
第一部分:化学品名称
化学品中文名称:
邻甲氧基苯酚
化学品英文名称:
o-methoxyphenol
中文名称2:
愈创木酚
英文名称2:
gulaiacol
技术说明书编码:
1659
CAS No:
1990-5-1
分子式:
C7H8O2
分子量:
124.13
第二部分:成分/组成信息
有害物质 含量 CAS No:
TLVWN:
未制订标准
工程控制:
严加密闭,提供充分的局部排风。
呼吸系统防护:
可能接触其粉尘时,必须佩戴防尘面具(全面罩);可能接触其蒸气时,应该佩戴自吸过滤式防毒面具(全面罩)。

RNA修饰中的核苷酸甲基化

RNA修饰中的核苷酸甲基化

RNA修饰中的核苷酸甲基化引言核酸甲基化是一种重要的RNA修饰形式,它通过在RNA分子上添加甲基基团来调节RNA的结构和功能。

在细胞中,核酸甲基化起到调控基因表达、细胞发育和疾病发生等重要作用。

本文将介绍核酸甲基化的基本概念、甲基化修饰的种类及其功能,以及核酸甲基化在疾病研究中的应用。

一、核酸甲基化的基本概念核酸甲基化是指在RNA分子上特定的核苷酸位置加上甲基基团。

常见的核酸甲基化包括N6-甲基腺嘌呤(m6A)、5-甲基胞嘧啶(m5C)和1-甲基肌苷(m1A)等。

这些甲基化修饰通常发生在RNA的转录过程中,在RNA合成完成后被加上甲基基团。

二、核酸甲基化修饰的种类及功能1. N6-甲基腺嘌呤(m6A)N6-甲基腺嘌呤(m6A)是最常见的RNA甲基化修饰。

它能够在RNA的剪接、稳定性和转运等方面发挥重要作用。

m6A修饰的存在可以影响RNA的二级结构和互作能力,从而调节RNA的翻译和降解过程。

此外,m6A还参与调控胚胎发育、细胞增殖和免疫应答等生物学过程。

2. 5-甲基胞嘧啶(m5C)5-甲基胞嘧啶(m5C)是一种能够在RNA链上特定位点加上甲基基团的修饰形式。

m5C修饰广泛存在于各种生物体中,包括人类细胞。

该修饰能够调控RNA的稳定性和翻译效率,并参与细胞的分化和发育过程。

此外,m5C还与疾病如癌症的发生和进展相关。

3. 1-甲基肌苷(m1A)1-甲基肌苷(m1A)是一种在RNA中存在的相对较少的甲基化修饰。

m1A修饰主要发生在RNA的tRNA分子上,能够调节tRNA的结构和功能。

该修饰可以影响tRNA的对接、翻译和识别能力,进而影响细胞的翻译过程和蛋白质合成。

三、核酸甲基化与疾病核酸甲基化在疾病研究中具有重要的应用价值。

许多疾病如癌症、神经系统疾病和心血管疾病与核酸甲基化的异常有关。

近年来,通过研究RNA甲基化修饰与疾病的关联,科学家们已经发现了一些潜在的治疗靶点和生物标志物。

以癌症为例,许多肿瘤细胞中的RNA甲基化模式与正常细胞不同,其中某些甲基化修饰水平的改变与肿瘤发生和进展有关。

每日专业名词通俗解释

每日专业名词通俗解释

每⽇专业名词通俗解释2022年03⽉01⽇HSCR⽂章的⼀些科普progenitor和precursor的区别The main difference between progenitor and precursor cells is that progenitor cells are mainly multipotent cells that can differentiate into many types of cells, whereas precursor cells are unipotent cells that can only differentiate into a particular type of cells.糖酵解glycolysis糖酵解(英语:glycolysis,⼜称糖解)是把葡萄糖(C6H12O6)转化成丙酮酸(CH3COCOO− + H+)的代谢途径。

在这个过程中所释放的⾃由能被⽤于形成⾼能量化合物ATP和NADH。

糖酵解作⽤及其各种变化形式发⽣在⼏乎所有的⽣物中,⽆论是有氧和厌氧。

糖酵解的⼴泛发⽣显⽰它是最古⽼的已知的代谢途径之⼀。

糖酵解作⽤是所有⽣物细胞糖代谢过程的第⼀步。

糖酵解作⽤是⼀共有10个步骤酶促反应的确定序列。

在该过程中,⼀分⼦葡萄糖会经过⼗步酶促反应转变成两分⼦丙酮酸。

糖酵解作⽤发⽣在⼤多数⽣物体中的细胞的胞质溶胶。

脂肪酸分解Fatty acid catabolism脂肪酸的氧化作⽤發⽣在粒線體(mitochondria)內,脂肪酸必須先和ATP反應,轉變為活化的中間產物,才能與其他酵素作更進⼀步的代謝,⾧鏈的Fatty acyl-CoA不能穿過粒線體內膜進⼊粒線體基質,需藉⾁酸素(carnitine)運送機制,脂肪酸氧化(Fatty acid oxidation)。

氧化磷酸化(英语:oxidative phosphorylation,缩写作 OXPHOS)是细胞的⼀种代谢途径,该过程在真核⽣物的线粒体内膜或原核⽣物的细胞膜上发⽣,使⽤其中的酶及氧化各类营养素所释放的能量来合成三磷酸腺苷(ATP)。

硝基脂肪酸

硝基脂肪酸

F ORUM R EVIEW A RTICLENitro-Fatty Acids:Formation,Redox Signaling,and Therapeutic PotentialAndre ´s Trostchansky,Lucı´a Bonilla,Lucı´a Gonza ´lez-Perilli,and Homero RubboAbstractSignificance:Nitrated derivatives of unsaturated fatty acids (nitro-fatty acids)are being formed and detected in human plasma,cell membranes,and tissue,triggering signaling cascades via covalent and reversible post-translational modifications of susceptible nucleophilic amino acids in transcriptional regulatory proteins and enzymes.Recent Advances:Nitro-fatty acids modulate metabolic as well as inflammatory signaling pathways,including the p65subunit of nuclear factor j B and the transcription factor peroxisome proliferator-activated receptor-c .Moreover,nitro-fatty acids can activate heat shock as well as phase II antioxidant responses.As electrophiles,they also activate the Nuclear factor erythroid 2-related factor 2pathway.Critical Issues:We first discuss the mechanisms of nitro-fatty acid formation as well as their key chemical and biochemical properties,including their capacity to release nitric oxide and exert antioxidant actions.The electrophilic properties of nitro-fatty acids to activate anti-inflammatory signaling pathways are discussed in detail.A critical issue is the influence of nitroarachidonic acid on prostaglandin endoperoxide H synthases,modulating inflammatory processes through redirection of arachidonic acid metabolism and signaling.Future Directions:Based on this information,we analyze in vivo data supporting nitro-fatty acids as promising pharmacological tools to prevent inflammatory diseases associated with oxidative and nitrative stress conditions.A key future issue is to evaluate whether nitro-fatty acid supplementation would be useful for human diseases linked to inflammation as well as their potential toxicity when administered by long periods of time.Antioxid.Redox Signal.19,1257–1265.Introduction Free as well as esterified fatty acids are key components of lipoproteins and cell membranes that can be affected by oxidative and nitrative stress conditions,characteristics of chronic inflammatory disorders (43).Nitric oxide ( NO)-derived species (NOx)react with unsaturated fatty acids yielding a variety of oxidized and nitrated products (49).In particular,nitroderivatives of long-chain unsaturated fatty acids containing a nitro-alkene group (NO 2-FA)have been identified,detected,and quantified in plasma as well as in cell membranes and tissue.They modulate metabolic as well as inflammatory signaling pathways (4,5,32,33,54,69),that is,induction of phase II antioxidant enzymes such as hemox-ygenase 1(HO-1)(57).In this review,we will discuss the key biological properties of NO 2-FA in terms of modulation of the expression and activity of enzymes as well as their capacity to modulate lipid oxidation, NO production,and signaling.Mechanisms of NO 2-FA FormationThe mechanism of fatty acid nitration in vivo remains un-known,with suggested pathways,including reactions of unsaturated fatty acids with secondary products of NO oxi-dation such as nitrogen dioxide ( NO 2),nitrite (NO 2-),and peroxynitrite (ONOO -)(Fig.1).Since NO 2can also initiate lipid oxidation reactions,the yields of the resultant products,for example,nitrated derivatives versus hydroperoxides products,will depend on O 2levels:at low O 2concentrations,nitrated product formation will predominate,while during aerobic conditions,additional lipid oxidation products such as hydroxyl,hydroperoxyl and ketoderived products will be favored (17,40).Nitrogen dioxide can be formed from NO auto-oxidation (45).In fact, NO freely diffuses into mem-branes and lipoproteins,due to its small molecular radius,neutral charge,and hydrophobic character.Nitric oxide auto-oxidation (Fig.1)is significantly accelerated in hydrophobicDepartment of Biochemistry,Faculty of Medicine and Center for Free Radical and Biomedical Research,University of the Republic,Montevideo,Uruguay.ANTIOXIDANTS &REDOX SIGNALING Volume 19,Number 11,2013ªMary Ann Liebert,Inc.DOI:10.1089/ars.2012.50231257compartments relative to the surrounding aqueous environ-ment.In fact,while cell membranes represent narrowly 3%of the total cell volume,around 90%of NO auto-oxidation takes place in this compartment (34,38).This is referred as the membrane-lens effect,where the concentration of NO and O 2inside the lipid bilayer is greatly enhanced due to a favoring partition,increasing the rate of reactions leading to NO 2formation despite the rather low reaction constant for NO auto-oxidation (k =1.5–3.0·106M -2s -1).Alternatively,NO 2can be formed from NO 2-(Fig.1).This should happen in vivo ,since NO 2-is present in physiological fluids and sa-liva from low nanomolar to high micromolar levels,respec-tively (35,41).Moreover,NO 2-should be exposed to low pH in the gastric compartment as well as in phagocytic lysosomes to generate NO 2;indeed,the human stomach is a source ofNO and bioactive nitrogen oxides from precursors present in food and saliva (35).A critical step is the protonation of NO 2-in the gastric lumen,thereby forming nitrous acid (HNO 2),which although being a nitrosating agent can also form NO,NO 2,and other nitrogen oxides (35).An additional lipid ni-tration mechanism involves peroxynitrite.Peroxynitrite anion (ONOO -)and peroxynitrous acid (ONOOH)are potent one-and two-electron oxidants that can react with unsaturated fatty acids yielding a variety of oxidation and nitration products,(45).Homolysis of ONOOH yields NO 2and hy-droxyl radical ( OH).In fact,ONOO -,ONOOH,and/or its derived radicals have been observed to readily diffuse through membranes to mediate fatty acid oxidation and nitration (Fig.1)(9,26,44,47,49).Several reports support NO 2-FA formation in vivo (12,15,39,51).In fact,nitroalkenes are present endogenously as free,esterified,and nucleophilic-adducted species (15);although reports about in vivo concentration have changed from themicromolar (4)to the picomolar range (66)in the past few years,their synthesis has been shown to be greatly increased in inflammatory models (15,39,55).During macrophage ac-tivation by an inflammatory stimulus,one of the major es-terified lipid component,cholesteryl linoleate (CL),becomes nitrated at the fatty acid moiety (15).The formation of cho-lesteryl-nitrolinoleate (NO 2-CL)by activated macrophages is prevented by NOS inhibitors,supporting the contribution ofNO-derived species toward CL nitration.Furthermore,the increase of CLNO 2in activated macrophages occurred in concert with increased inducible nitric oxide synthase (NOS2)expression and activity.Thus,overproduction of NO could drive lipid nitration,and the generated nitroalkenes may act as endogenous,secondary mediators capable of attenuating NOS2expression and limiting the proinflammatory actions ofNO-derived reactive species.More recently,it has been demonstrated that NO 2-FA is both present and formed in the mitochondria from cardiac ischemia/reperfusion (51)or is-chemic-preconditioned (IPC)(39)hearts.In mice subjected to coronary artery ligation,nitro-linoleic (NO 2-LA)and nitro-oleic acids (NO 2-OA)were detected after 30min of reperfu-sion without detection of NO 2-FA in mice with myocardial infarction without reperfusion (51);however,while both NO 2-LA and NO 2-OA were present in the mitochondria at levels of fmol/mg of tissue protein,only NO 2-LA increased after IPC (39).Release of NO by Nitro-Fatty AcidsNitroalkenes decay faster in phosphate buffer than in or-ganic solvent due to solvation in aqueous solutions (4,32,54).While this process is accompanied by the release of NO,it has been demonstrated that NO released from NO 2-LA,NO 2-OA,or nitro-arachidonic acid (NO 2-AA)was <1%of the ni-trated fatty acid (19,32,54,65).In contrast to nitrates (i.e.,nitroglycerin)(42),the release of NO by nitroalkenes is in-dependent of the presence of thiol adjuvants such as cysteines,and in the case of NO 2-AA was observed only in the presence of superoxide dismutase (SOD)(65).Same requirement of SOD was reported when analyzing NO release form nitro-glycerin/cysteine (42).Different observations were obtained in macrophages and endothelial cells (8,65).It has been well established that ara-chidonic acid (AA)-signaling cascades and NO pathways are intrinsically related (52).In activated macrophages,NO 2-AA exert protective anti-inflammatory actions diminishing NOS2expression as well as secretion of proinflammatory cytokines (65).In addition,micromolar levels of NO 2-AA caused a re-duction of NO generation.We asked if NO released during macrophage activation could have an inhibitory impact on NOS2activity.However,exogenously added NO did not decrease NO generation by activated macrophages,confirm-ing that changes in NOS2expression were not associated withNO released during NO 2-AA decay (65).Downregulation of NOS2by nitroalkenes should contribute to the physio-logical shut down of inflammatory responses in macrophages (Fig.2).Quite different results were obtained when analyzing the methyl ester derivative of NO 2-AA (Met6-NO 2-AA)(8).While we were unable to detect NO from Met6-NO 2-AA in aqueous solution, NO release was observed in the presence of endothelial cells,suggesting that esterified nitroalkenes would be able to generate NO/ NO-like species in acellularFIG.1.Mechanisms of unsaturated fatty acid nitration.Nitrogen dioxide can be formed by at least three major bio-logically relevant mechanisms (see text)and react with un-saturated fatty acids to preferentially form (at low oxygen tensions)nitroalkenes (nitro-group bonded at the double bond)and nitroallyl derivatives (nitro-group bonded at a single bond).1258TROSTCHANSKY ET AL.environment (8).In both NO 2-AA-and Met6-NO 2-AA-treated endothelial cells,cGMP levels increased,suggesting that gua-nylate cyclase was activated directly or via NO/ NO-like species (8).Another issue to take into account is related to the capacity of nitroalkenes to react with nucleophilic residues in proteins (for more discussion,see below).Most of circulating NO 2-FA are adducted to proteins,that is,human albumin (55),thus preventing the formation of NO by the mechanisms discussed above.Indeed,systemic administration of NO 2-OA to nonhypertensive mice was unable to modify blood pressure discarding any in vivo relevance for NO release from ni-troalkenes during NO 2-OA administration (72).Overall,while can reduce the formation of NO during inflammatory processes by diminishing NOS expression,we can conclude that in vivo NO 2-FA signaling and antioxidant effects will not be ascribed to their capacity to release NO.While affecting NO,nitroalkenes may also alter the for-mation of superoxide radical (O 2-)during macrophage acti-vation by modulating the phagocytic NADPH oxidase (NOX2)(Fig.2)(2,10).Recent data show that NO 2-AA in-hibits NOX2-mediated O 2 -production in activated macro-phages (Gonzalez et al.,submitted).The mechanism involves prevention of the migration of the cytosolic subunits to the membrane,thus inhibiting the correct assembly of the active enzyme.This inhibitory role of nitroalkenes observed during macrophage activation,in addition to the decrease in NOS2expression,could facilitate the resolution of inflammation (10,28).Nitro-Fatty Acid Protective Effects on Lipoprotein OxidationLipid oxidation is involved in chronic inflammatory dis-eases such as atherosclerosis.In fact,a key early event in the pathogenesis of atherosclerosis is the oxidation of low-density lipoprotein (LDL)exposed to oxidative/nitrative stress con-ditions.A direct consequence of oxidative damage in a lipo-protein milieu is the formation of lipid–protein adducts leading to proinflammatory as well as pro-oxidant events.In these scenarios,the high rate and broad distribution of NO production,combined with its facile reactions with oxygen radical species assure that NO will play a central role in regulating critical oxidant reactions in LDL.Although NO-derived metabolites may exert oxidative modifications in LDL through peroxynitrite formation, NO 2and/or the nitrite–myeloperoxidase system (29,58), NO itself inhibits lipid oxidation-dependent processes (21,48).Nitric oxide causes a prolongation of the lag time as well as inhibition of the propagation phase of LDL oxidation through its chain-breaking activity (20,48).Moreover,fragmentation of apo-lipoprotein B-100by oxidants,loss of amino groups,and protein–lipid fluorescent adduct formation is prevented byNO (62).The formation of lipid peroxidation-dependent antigenic epitopes in oxidized LDL results also inhibited byNO (58).Thus, NO released by nitroalkenes may play an antioxidant and protective role on lipid as well as LDL oxi-dation.However,as explained above,the levels of releasedNO may not be enough to directly protect lipids in LDL from oxidative stress.In fact,nitroalkene-mediated NO release would be inhibited within the lipophilic lipoprotein milieu,making it unlikely for this mechanism to prevent the propa-gation of lipid oxidation reactions.Alternatively, NO would be released from NO 2-FA that are free in the circulation (i.e.,in the aqueous phase);the efficiency of this process to generate sufficient quantities of NO to avoid scavenging by hemo-globin and still sustain an antioxidant role remains unknown.While endogenous NO 2-FA concentrations are not probably enough to exert a significant antioxidant activity through anNO release mechanism,this activity should be considered within pharmacological dosing.Moreover,under nitro-oxidative stress conditions,NO 2-FA could modulate oxi-dative pathways representing novel footprints of tissue oxidative damage.This can counteract the proinflammatory activities of lipid-and protein-oxidized products due to the ability of NO 2-FA to exert a variety of anti-inflammatory and cell-signaling properties (4,57).Electrophilic Properties of Nitro-Fatty AcidsNitroalkenes are potent electrophiles;the addition of a nitro group (–NO 2)to a double bond at the carbon chain of the unsaturated fatty acids leads to an alkenyl nitro-configuration with electrophilic reactivity of the b -carbon adjacent to the nitro-bonded carbon.Through Michael addition reactions,nitroalkenes can react with nucleophiles yielding new carbon–carbon or carbon–heteroatom bond framework (1,3,7).Biochemical studies reveal that NO 2-FA rapidly and re-versibly undergoes Michael addition with thiols and to a lesser extent primary and secondary amines (i.e.,Cys or His residues)(1,3,7).In contrast to other lipid derived-electro-philes,nitroalkylation of Cys and His is reversible (1,7,55).Through this mechanism,NO 2-FA alkylate-susceptible thiols of multiple transcriptional regulatory proteins,affecting downstream gene expression and the metabolic and inflam-matory responses under their regulation (Table 1).Recent preliminary data show that nitroalkenes can modify the protein a -synuclein (a -syn)in His50leading to a decrease in protein aggregation compared to 4-hydroxynonenal (Table1).FIG. 2.Signaling of NO 2-AA in macrophages.Nitro-arachidonic acid (NO 2-AA)has been shown to exert anti-inflammatory actions in macrophages due to an inhibition of NOS2expression and NOX2assembly,while activating the Nrf2/ARE pathway inducing the expression of phase II an-tioxidant enzymes,that is,HO-1and GST.ARE,antioxidant-response element;HO-1,hemoxygenase 1;NOS2,inducible nitric oxide synthase;NOX2,phagocytic NADPH oxidase;Nrf2,nuclear factor E2-related factor 2.NITRO-FATTY ACIDS SIGNALING AND THERAPEUTICS 1259This example illustrates a novel capacity of NO 2-FA to exert anti-inflammatory actions through Michael addition adducts that could down-modulate proinflammatory lipid–protein adducts formation.Another example of the electrophilic ac-tions of nitroalkenes is their ability to inhibit angiotensin-II (Ang-II)-dependent vasoconstriction (72).This occurs at the Ang-II type I receptor (AT 1)level,where NO 2-OA covalently modified the AT 1receptor without affecting Ang-II binding (72).Activation of Anti-Inflammatory Signaling Pathways The transcriptional factors PPAR have been found to serve as nuclear receptors capable of selectively binding NO 2-FA.Analysis of cDNA prepared from nitroalkene-treated human aortic smooth muscle cells showed that nitroalkenes are able to potently regulate the expression of multiple PPAR target genes (31,57,68).The effects of NO 2-FA on full-length PPAR receptors were then tested in transfection assays using a peroxisome proliferator-activated receptor-gamma (PPAR c )-response reporter,where nitroalkenes potently activated all PPAR subtypes,having a stronger activity on PPAR c than PPAR a and PPAR b /d (12).PPAR c has been associated with anti-inflammatory actions such as modulation of the expres-sion of several proinflammatory cytokines and chemokines in activated macrophages.In addition,NO 2-OA is able to co-valently react with Cys 285in PPAR c ,and its administration to ob/ob mice showed a decrease of insulin and glucose levels without inducing adverse side effects,showing the in vivo biological relevance of this interaction (56).Various mechanisms,apart from PPAR c modulation,have been proposed to explain the protective actions exerted by ni-troalkenes.One of them involves the inhibition of the nuclear factor-kappa B (NF-j B)translocation to the nucleus (12,51).In fact,NF-j B plays an important role during inflammatory responses regulating genes that encode proinflammatory cy-tokines.Both NO 2-LA and NO 2-OA inhibit lipopolysacharide-induced secretion of proinflammatory cytokines in macrophages (e.g.,IL-6,TNF a ,and MCP-1).The observed effects resulted from the covalent alkylation of recombinant NF-j B p65pro-tein in vitro and a similar reaction with the p65subunit in macrophages.The inhibition of NF-j B migration to the nu-cleus inhibited DNA-binding activity and repressed NF-j B-dependent target gene expression in addition to the inhibitionof the expression of the vascular cell adhesion molecule 1as well as monocyte rolling and adhesion (12).Hemeoxygenase-1catalyzes the oxidative degradation of heme to biliverdin exerting antioxidant and anti-inflammatory actions.The induction of HO-1is an endogenous cytoprotec-tive pathway triggered by a variety of stress-related signals and electrophilic species (16,53).Nitroalkenes (NO 2-LA,NO 2-OA,and NO 2-CL)induce HO-1expression in endothelial cells (70),RAW264.7(12),and J774.1macrophages (15)by PPAR c -independent and both NO-dependent and independent mechanisms (70).Considering the vascular protective effects of HO-1expression,HO-1represents a key novel cell signaling action of nitroalkenes.Nuclear factor E2-related factor 2(Nrf2),a member of the cap-n-collar family of basic region leucine-zipper transcription factors,is a mediator of antioxidant and phase II detoxifying enzyme expression,that is,HO-1(13,18,23).Nrf2is a transcription factor that is in an inactive form at the cytosol due to the activity of Keap1.When activated,Nrf2migrates to the nucleus and binds as an heterodimer to the antioxidant-response element (ARE)in DNA,activating the expression of phase 2enzymes (13).Potential activators for Nrf2include lipid electrophiles that react with reactive Keap1thiols dissociating Nrf2from the ubiquitin E3ligase complex and facilitating nuclear accumulation and downstream effects on gene transcription (13).Keap1is highly reactive to ni-troalkylation since constitutes a cysteine-rich protein (13,18,23).Diverse functional studies using Keap1mutants showed that Cys 151is an electrophile sensor residue whose adduction causes the dissociation of Keap1from Cul3,preventing Nrf2proteasomal degradation and allowing the activation of its target genes via binding to AREs (14,30,71).However,NO 2-OA is a Cys 151-independent Nrf2activator,as Keap1Cys 151mutants remain unaffected by the nitroalkene enhanc-ing,instead of diminishing,the binding of Keap1with Cul3(24).Like HO-1,Nrf2activation confers protection to different cell types against oxidative stress.In this way,vascular smooth muscle cell (VSMC)proliferation is inhibited by physiological levels of nitroalkenes (69).The signaling pathway that partici-pates in this action involves the Nrf2/ARE system.During VSMC inhibition of proliferation,Nrf2nuclear translocation is enhanced by NO 2-FA,suggesting that this signaling cascade is also involved in the observed anti-inflammatory actions of ni-troalkenes (69).We have been also observed that nitroalkenes increase the intracellular antioxidant capacity by induction of glutamate–cysteine ligase via the Nrf2/ARE pathway,thus increasing glutathione levels (unpublished results).Using hu-man aortic endothelial cells,the role of NO 2-FA on the Nrf2pathway was further explored (25).The expression of Nrf2-dependent genes,including heme oxygenase-1and glutamate cysteine ligase modifier subunit,was significantly stimulated by NO 2-OA;however,array analyses showed that the ma-jority of NO 2-OA-regulated genes were regulated by Nrf2-independent pathways.Deeper studies demonstrated that the heat shock response is the major pathway activated by NO 2-OA (25).In fact,NO 2-OA induced in a great extent many heat shock transcription factor-regulated heat shock genes (25).Reg-ulation of the heat shock response is a novel anti-inflammatory and cytoprotective action of NO 2-FA in addition to the other protective cell signaling functions reported for nitroalkenes.Inflammation elicits pain and reflexes as a result of the activation of somatosensory and visceral nociceptive sensory nerves.Lipid oxidation products are able to covalent modifyTable 1.Covalently Modified Proteins by NO 2-FA Modified proteinReferenceGlyceraldehyde 3-phosphate dehydrogenase (GAPDH)Batthyainy et al.(7)Peroxisome proliferator-activated receptor-gamma (PPAR c )Schopfer et al.(57)Angiotensin II-type I receptor (AT 1)Zhang et al.(72)Nuclear factor j B (NF j B)Cui et al.(12)Kelch-like ECH-associated protein-1(Keap-1)Kansanen et al.(24)Uncoupling protein-2(UCP-2)Nadtochiy et al.(39)a -Synuclein (a -Syn)Souza et al.(unpublished results)1260TROSTCHANSKY ET AL.N-terminal cysteine groups in the transient receptor potential (TRP)ion-channel family,for example,TRPA1thus activating nociceptive neurons(61).In this way,NO2-OA was able to activate wild-type TRPA1in contrast to the Cys-mutated forms of the channel in an NO-independent mechanism,thus contributing to nociception in inflammation(61).The Case of Prostaglandin Endoperoxide H Synthase Prostaglandin endoperoxide H synthase(PGHS)is a key enzyme of AA metabolism,catalyzing the formation of prostaglandin H2(PGH2)(37,46,67).Thefinal product of PGHS catalysis is metabolized to different products depending on the cell type(46,59).Two isoforms of PGHS(PGHS-1 and2)are found in mammalian tissues.PGHS-1is constitu-tively expressed,whereas PGHS-2is an inducible enzyme. Both isoforms are of pharmacological importance,because they are targets for nonsteroidal anti-inflammatory drugs(36). Prostaglandin H2formation by PGHS catalysis involves two separate reactions at different active sites(37,46,67):a)the oxidation of AA to yield PGG2performed by the cycloox-ygenase(COX)reaction,where two molecules of oxygen are added to AA;and b)the reduction of the hydroperoxyl group at the C15by the peroxidase(POX)reaction yielding PGH2 (46,60,67).We have recently evaluated the interaction of the nitrated derivative of AA with PGHS(63).The POX activity inhibition exerted by NO2-AA was time-and concentration-dependent in both PGHS-1and2with kinetic analysis, suggesting a two-step mechanism of inactivation:an initial reversible binding,followed by a practically irreversible event leading to an inactivated enzyme.Inactivation was associated with an irreversible disruption of heme binding to the protein. The observed effects for NO2-AA were selective,since other nitroalkenes tested were unable to inhibit enzyme activity.In activated human platelets,NO2-AA significantly de-creased PGHS-1-dependent thromboxane-B2formation in parallel with a decrease in platelet aggregation,thus con-firming the biological relevance of this novel inhibitory pathway(63).These antiplatelet effects were cGMP inde-pendent and did not involve Ca2+store-dependent mobili-zation,providing a possible novel mechanism for platelet regulation in vivo.We also studied the modulatory role of NO on peroxyni-trite-dependent PGHS-1inhibition:while NO spared POX,it enhanced COX inactivation by peroxynitrite.Hydrophobic environments facilitate reactions where NO, NO2,arachi-donyl(AA ),and arachidonyl peroxyl(AAOO )radicals are likely to be simultaneously present,that is,COX active site during enzyme turnover(27,37,46).The half-life of AAOO (0.1–0.2s)is sufficiently long for the reaction with NO2to occur,leading to arachidonyl peroxynitrites(AAOONO)/ni-trates that could rearrange into NO2-AA,AA(OH)NO2,and nitroepoxyarachidonate(6).Thus,during PGHS-1-COX ca-talysis,AA-derived radicals could fast react with NO to form nitrogen-containing AA products,which in turn inhibit COX, modulating inflammation through redirection of the AA-signaling pathway(Fig.3).Therapeutic PotentialWhile the biochemical mechanisms leading to lipid nitration are under active investigation,there is an unambiguous evi-dence of their formation in vivo as well as their increase during inflammatory conditions.The reported concentrations start in the nanomolar(66)to low micromolar range(4).These con-centrations are enough to exert biological actions,including inhibition of platelet and macrophage activation(11,65), proinflammatory cytokine secretion(57),andVSMCFIG.3.Enzymatic formation of NO2-AA and its effects on platelet function.(A)Platelet stimulation leads to PLC activation,diacylglycerol and Ca2+release,and PLA2-mediated AA release from membrane phospholipids.AA enters the PGHS-1pathway to form PGH2,which is transformed to the proaggregant TxA2by TxA2synthase.In addition,DAG activates conventional PKC isoforms leading to an enzymatic intracellular cascade leading to platelet aggregation.AANO2 administered to human platelets inhibits both PGHS-1and conventional PKC isoform activities.(B)Arachidonyl radical is an intermediary during PGHS catalysis and we believe that under pro-inflammatory conditions NO2could overreact O2during the cyclooxygenase activity leading to the catalytically controlled synthesis of NO2-AA,thus representing a novel mechanism for regulating PGHS as well as platelet activity in vivo.Modified from(64).AA,arachidonic acid;PLC,phospholipase C; PLA2,phospholipase A2;PGHS,prostaglandin endoperoxide H synthase;PGH2,prostaglandin endoperoxide H2;TxA2, thromboxane A2;PKC,protein kinase C.NITRO-FATTY ACIDS SIGNALING AND THERAPEUTICS1261proliferation(69).However,to exert a chain-breaking antioxi-dant activity,that is,during LDL oxidation,greater nitroalkeneconcentrations should be needed.In light of the above,the an-tioxidant role of NO2-FA may occur mainly due to its signaling actions increasing the levels of phase II enzymes instead ofthe classical chain-breaking activity already described for NO.Thus,it is possible that at the levels expected to be found in vivo during chronic inflammatory conditions,nitrated lipidsmay serve as antioxidant and anti-inflammatory agents, partially counteracting proinflammatory effects of oxidant exposure.There are emerging data on the therapeutic potential ofNO2-FA:our laboratory recently explored a model of in-flammation based on thioglycolate injection into mouse peritoneum(73),evaluating the effects of NO2-AA adminis-tration on macrophage activation.Subcutaneous injection of low micromolar concentrations of NO2-AA decreased mac-rophage activation,indicating that NO2-AA is capable to exert anti-inflammatory effects in vivo(Gonzalez et al.,submitted). There are several reports using NO2-FA as pharmacological modulators of inflammatory-related diseases in animal models(39,51,72).Of interest,NO2-OA subcutaneous ad-ministration to Ang-II-treated mice significantly lowered the increase in blood pressure as well as the contractile response to Ang-II in mesenteric arteries(72).As explained before, NO2-OA,but not OA,binds to the AT1R-modulating intra-cellular signaling cascades(inositol-1,4,5-trisphosphate and calcium mobilization)(72).Overall,the reported results show that NO2-OA diminishes the pressor response to Ang II,in-hibiting AT1R-dependent vasoconstriction and suggesting that NO2-OA can be a pharmacological relevant modulator of Ang II-induced hypertension(72).Nitroalkenes were also tested in C57/BL6mice subjected to coronary artery ligation followed by30-min reperfusion(I/R).Under these experi-mental conditions,both NO2-OA and NO2-LA were formed. When administered exogenously during the ischemic epi-sode,NO2-OA was able to exert protection against I/R injury, reducing the infarct size as well as preserving the left ven-tricular function(51).The proposed mechanisms involve NO2-OA-mediated inactivation of the p65subunit of NFkB in I/R tissue as well as to suppression of downstream intercel-lular adhesion molecule1,monocyte chemotactic protein1 (MCP-1),neutrophil infiltration,and myocyte apoptosis(51). The same group of researchers evaluated the capacity of NO2-FA to modulate atherosclerosis,a chronic inflammatory dis-ease(50).Subcutaneous administration of NO2-OA potently reduced atherosclerotic lesion formation in apolipoprotein E-deficient mice(50).Atherosclerotic lesions of NO2-OA-treated animals showed an increased content of collagen and smooth muscle actin,suggesting conferral of higher plaque stability. Overall,the results reveal the antiatherogenic potential of electrophilic NO2-FA.Reactive lipid species,including NO2-FA,participate in several physiological pathways due to their electrophilic ca-pacity through modification of specific signaling proteins(22). The formation of covalent adducts with proteins gives par-ticular characteristics to the signaling capacity of NO2-FA, leading the accumulation of a signal over time.Moreover,the reversibility of the covalent reaction can transform NO2-FA into important intracellular mediators(55).In fact,low elec-trophile concentrations may accumulate over time(22), leading to a persisting signaling while higher concentrations should activate a wide array of signaling cascades.Although beneficial effects of NO2-FA in different in vivo models are clearly demonstrated(12,39,51,55,72),there are still no re-ports evaluating the potential toxicity that these compounds could exert when administrated for longer periods of time.In addition,the way that NO2-FAs are administered should have effects in the levels reached in vivo(i.e.,intraperitoneal versus subcutaneous)with the concomitant signaling and biological effects that may vary according to the circulating or tissue levels of the electrophiles.Concluding RemarksMost of the quantitation studies of NO2-FA in biological samples have been performed using nitroalkenes as stan-dards.However,there are other structural possibilities for NO2-FA as well as different positional isomers that should be present in biological samples,which remain to be studied.An important issue to be considered in biological tissues is that NO2-FA will be present in free and esterified forms,and the release and stability of NO2-FA may differ in different com-partments and must be mobilized through the activity of es-terases and phospholipases(54).Thus,detection and quantitation of nitrated lipids in vivo are complex,being de-termined by the biological environment and abundance of target molecules.Even these limitations,it should be consid-ered that very small quantities of NO2-FA(in the nanomolar range)will be enough to mediate potent signaling transduc-tion cascades.Thus,it is possible that at the levels expected to be found in vivo during inflammatory conditions,nitrated lipids may serve not only as biomarkers of pathophysiological processes but also as protective agents diminishing the proinflammatory effects of oxidant exposure.Further work is necessary to determine whether NO2-FA supplementation would exert novel anti-inflammatory and tissue-protective actions in human diseases.AcknowledgmentsThis work was supported by grants from Fondo Marı´a Vin˜as-ANII(FMV_2913)to A.T.,ICGEB(Italy)and CSIC-Uruguay to H.R.L.B.and L.G.were partially supported by fellowships from Sistema Nacional de Becas-ANII. References1.Alexander RL,Bates DJ,Wright MW,King SB,and MorrowCS.Modulation of nitrated lipid signaling by multidrug re-sistance protein1(MRP1):glutathione conjugation and mrp1-mediated efflux inhibit nitrolinoleic acid-induced, ppargamma-dependent transcription activation.Biochem-istry45:7889–7896,2006.2.Alvarez MN,Trujillo M,and Radi R.Peroxynitrite formationfrom biochemical and cellularfluxes of nitric oxide and su-peroxide.Methods Enzymol359:353–366,2002.3.Baker LM,Baker PR,Golin-Bisello F,Schopfer FJ,Fink M,Woodcock SR,Branchaud BP,Radi R,and Freeman BA.Nitro-fatty acid reaction with glutathione and cysteine.Ki-netic analysis of thiol alkylation by a Michael addition re-action.J Biol Chem282:31085–31093,2007.4.Baker PR,Lin Y,Schopfer FJ,Woodcock SR,Groeger AL,Batthyany C,Sweeney S,Long MH,Iles KE,Baker LM, Branchaud BP,Chen YE,and Freeman BA.Fatty acid transduction of nitric oxide signaling:multiple nitrated1262TROSTCHANSKY ET AL.。

阿替洛尔(标准品)

阿替洛尔(标准品)

中文品名阿替洛尔(标准品)
CAS 号29122-68-7
英文品名Atenolol
分子式:C14H22N2O3 分子量:266.34
检测条件:
方法:HPLC
流动相:…………………………………磷酸盐缓冲液-甲醇(70:30)
检测波长:…………………………….226nm
色谱柱:…………………………………十八烷基硅烷键合硅胶为填充剂
用途:对照标准品,用于分析对照,含量测定
阿替洛尔(标准品)的溶解性,阿替洛尔(标准品)在水中的溶解性,阿替洛尔(标准品)在生理盐水中的溶解性,阿替洛尔(标准品)在PBS缓冲液中的溶解性,阿替洛尔(标准品)在DMSO、乙醇等有机溶剂中的溶解性,阿替洛尔(标准品)在细胞实验方面的应用,阿替洛尔(标准品)在大鼠等动物实验方面的应用。

吩噻嗪类衍生物

吩噻嗪类衍生物

1. Introduction Phenothiazines are important psychotropic compounds, but they also have further biological activities.1–3 For example, phenothiazines have recently been considered as potential drugs in the management of CreutzfeldtJacob disease.4 Metabolism of phenothiazine-based drugs often results in the formation of 7-hydroxylated derivatives or 5-sulfoxides.5–7 Because oxidation of asymmetrically substituted phenothiazines at the S(5) position introduces a new stereogenic center, these 5-sulfoxides are chiral. Although chiral 5-sulfoxide metabolites of the phenothiazine drug thioridazine in human plasma were separated by HPLC,8 to date optically active phenothiazine 5-oxides have not been obtained on preparative scale. Hence, stereoselective methods for the synthesis of optically active phenothiazine-5-oxides would extend the possibilities for investigation of the S -oxide metabolites of phenothiazine-based drugs.

奥罗那(注射用盐酸托泊替康)

奥罗那(注射用盐酸托泊替康)

奥罗那(注射用盐酸托泊替康)【药品名称】商品名称:奥罗那通用名称:注射用盐酸托泊替康英文名称:Tetracycline Hydrochloride Capsules【成份】本品为盐酸拓扑替康的无菌冻干品。

【适应症】小细胞肺癌,晚期转移性卵巢癌经一线化疗失败者。

【用法用量】1.剂量:推荐剂量为m2/日,静脉滴注30分钟。

持续5天,21天为一疗程,治疗中严重的中性粒细胞减少症患者,在其后的疗程中剂量减少m2或与G-CSF同时使用。

使用从第6天开始,即在持续5天使用本品后24小时后再用G-CSF 。

2.注射液配制:用无菌注射用水1m1溶解本品1mg比例溶解本品,按m2/日剂量抽取药液,用%氯化钠或5%葡萄糖注射液稀释后静脉滴注。

3.特殊人群的剂量调整肝功能不全者:肝功能不全(血浆胆红素~10mg/dl)患者,血浆清除率降低,但一般不需剂量调整。

肾功能不全者:对轻微肾功能不全(CLcr40~60ml/分钟)一般不需剂量调整,中度肾功能不全(CLcr20~39ml/分钟)剂量调为m2,没有足够资料可证明在严重肾功能不全者可否使用。

【不良反应】1、血液系统:有白细胞减少、血小板减少、贫血等反应。

骨髓抑制(主要是中性粒细胞)是本品的剂量限制性毒性,治疗期间要监测外周血象,在治疗中中性粒细胞恢复至〉1500个/mm3,血小板恢复至100000个/mm3,血红蛋白恢复至dl方可继续使用(必要时可使用G-CSF或输注成分血)。

与其它细胞毒药物联合应用时可加重骨髓抑制。

2、消化系统:恶心、呕吐、腹泻、便秘、肠梗阻、腹痛、口腔炎、厌食。

3、皮肤及附件:脱发、偶见严重的皮炎及搔痒。

4、神经肌肉:头痛、关节痛、肌肉痛、全身痛、感觉异常。

5、呼吸系统:可致呼吸困难。

虽然尚不能肯定是否会因此造成死亡,但应引起医生的重视。

6、肝脏:有时出现肝功能异常,转氨酶升高。

7、全身:乏力、不适、发热。

8、局部:静脉注射时,若药液漏在血管外可产生局部刺激、红肿。

海绵动物和刺细胞动物

海绵动物和刺细胞动物
生态修复与保护
研究海绵动物和刺细胞动物的生态修复潜力,为 其在海洋生态保护中的应用提供科学依据。
挑战与机遇并存
采样困难
海绵动物和刺细胞动物多分布于深海等难以到达的区域,采样困难 ,限制了对其深入研究。
毒素安全问题
部分刺细胞动物毒素具有强烈毒性,研究过程中需加强安全防护措 施。
跨学科合作
海绵动物和刺细胞动物研究涉及生物学、化学、生态学等多个学科领 域,需要加强跨学科合作与交流,推动研究成果的转化应用。
生态环境
海绵动物广泛分布于各种海洋环境中,从浅海到深海、从热带到寒带都有它们的 踪迹。它们通常附着在岩石、贝壳、珊瑚等硬质基底上生长,有些种类还能在泥 沙中生活。
02
刺细胞动物概述
定义与分类
刺细胞动物定义
刺细胞动物是一类具有刺丝囊(cnidocytes)的海洋生物,属于刺胞动物门(Cnidaria)和栉水母动 物门(Ctenophora)。
主要分类
根据形态和生态特征,刺细胞动物可分为水螅虫纲(Hydrozoa)、钵水母纲(Scyphozoa)、珊瑚 虫纲(Anthozoa)和栉水母纲(Ctenophora)。
形态特征与多样性
形态特征
刺细胞动物身体柔软,呈辐射对 称或两侧对称,具有刺丝囊以进 行捕食和防御。多数种类具有触 手,且触手上布满刺细胞。
细胞动物的利用不会破坏生态平衡。
公众教育
03
加强公众对海洋生态系统和生物多样性保护的认识和教育,提
高公众的环保意识和参与度。
05
研究现状与未来展望
当前研究热点及成果
海绵动物基因组学研究
揭示海绵动物的进化地位、物种多样性和基因组特点。
刺细胞动物毒素研究
发现多种具有药用价值的刺细胞动物毒素,并研究其作用机制和应 用前景。

DETOXIFIED LPS-CHOLERA TOXIN CONJUGATE VACCINE FOR

DETOXIFIED LPS-CHOLERA TOXIN CONJUGATE VACCINE FOR

专利名称:DETOXIFIED LPS-CHOLERA TOXINCONJUGATE VACCINE FOR PREVENTION OFCHOLERA发明人:SZU, Shousun, C.,ROBBINS, John, B.,GUPTA, Rajesh, K.申请号:EP93903428.0申请日:19930114公开号:EP0623026A1公开日:19941109专利内容由知识产权出版社提供摘要: The invention discloses a vaccine formulation comprising the conjugated compounds of LPS and detoxified proteins comprising the cholera toxin (CT). The treatment with hydrazine (DeA-LPS) reduced endotoxic properties of LPS to acceptable levels, and produces a larger molecule, and activity / antigen increased, relative to the saccharide produced by acid hydrolysis. Conjugates using the V. cholerae toxin are described, which exhibit low levels of pyrogens, no toxic activity with respect to ovary cells Chinese hamster, and induce reinforcing responses in vibriocidal antibody and antibodies against the toxin cholera when injected subcutaneously as saline solutions in mice. The conjugate produced as vaccine against cholera induce the formation of the same antibody as cellular vaccines parenteral injection but show immunological characteristics and improved safety.申请人:THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 地址:National Institute of Health, Office of Technology Transfer, Westwood Building,Box OTT Bethesda, MD 20892-9902 US 国籍:US代理机构:VOSSIUS & PARTNER更多信息请下载全文后查看。

干口蘑的抗衰老和抗氧化机制探究

干口蘑的抗衰老和抗氧化机制探究

干口蘑的抗衰老和抗氧化机制探究简介:干口蘑,又被称作松茸、黑松露,是一种珍贵的食用菌。

在传统中医和日本草药学中,干口蘑素有“神药”之称。

研究表明,干口蘑具有抗衰老和抗氧化的作用。

本文将探讨干口蘑的抗衰老和抗氧化机制。

一、干口蘑的抗衰老机制1.1 抗氧化作用干口蘑富含多种抗氧化物质,如多酚、维生素C、维生素E和花青素等。

这些抗氧化物质能够中和自由基,减少细胞氧化损伤并延缓衰老过程。

研究表明,干口蘑中的多酚具有较强的自由基清除能力,能够有效抑制脂质过氧化反应和蛋白质氧化反应,保护细胞免受氧化损伤,延缓细胞衰老。

1.2 抑制炎症反应慢性炎症是衰老过程中的重要因素之一。

干口蘑中的活性成分能够抑制炎症反应,减少炎性介质的产生和炎症细胞的浸润。

研究发现,干口蘑中的多糖具有良好的抗炎活性,能够抑制炎性细胞因子如白介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)的产生,从而减缓炎症反应,保护细胞免受炎症伤害。

1.3 促进自噬自噬是细胞清除代谢产物和受损细胞成分的方式之一,对于保持细胞内环境的稳定以及延缓衰老有重要作用。

研究发现,干口蘑中的活性成分能够促进自噬通路的调控,增强细胞自噬功能。

通过促进自噬,干口蘑可以清除细胞内的老化蛋白质和细胞器垃圾,提高细胞的代谢和修复能力,延缓细胞衰老的发生。

二、干口蘑的抗氧化机制2.1 活性物质干口蘑含有丰富的多酚化合物,如松皮酮、青松乙酮和青松醇等。

这些多酚化合物具有强大的抗氧化活性,能够清除体内的自由基,减轻氧化应激的损伤。

2.2 调节氧化还原平衡干口蘑中的抗氧化物质能够调节氧化还原平衡,维持体内的氧化还原状态。

研究发现,干口蘑中的活性成分能够调节线粒体氧化还原系统的功能,增强抗氧化酶的活性,提高细胞的自我修复能力,保护细胞免受氧化损伤。

2.3 保护细胞膜完整性氧化应激会导致细胞膜的损伤,进而引起细胞功能异常和衰老加速。

干口蘑中的多酚类物质能够保护细胞膜的完整性,减少膜脂质的氧化损伤。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

COMMUNICATION /obc |Organic &Biomolecular ChemistryA thiophen-thiooxorhodamine conjugate fluorescent probe for detecting mercury in aqueous media and living cells†Yi Zhou,Xue-Yan You,Yuan Fang,Ju-Ying Li,Ke Liu and Cheng Yao*Received 19th July 2010,Accepted 3rd September 2010DOI:10.1039/c0ob00452aA rhodamine-based sensor RB-S2was designed and synthe-sized by combination of the thiospirolacton chromophore and the thiophen ring block with high affinity to Hg 2+.Probe RB-S2exhibits high selectivity and excellent sensitivity in both absorbance and fluorescence detection of Hg 2+in aqueous solution.In addition,fluorescent imaging of Hg 2+in MCF-7cells is also successfully demonstrated.The fluorescent chemosensors are powerful tools to monitor in vitro and/or in vivo biologically relevant species such as metal ions because of the simplicity and high sensitivity of fluorescence.1Mercury is considered as a prevalent toxic and dangerous heavy metal element because of its high affinity for thiol group in proteins and enzymes,leading to the dysfunction of cells and consequently causing many health problems in the brain,kidney,central nervous,mitosis and endocrine system.2Generally,Hg 2+is known to cause fluorescence quenching of the fluorophores via the spin–orbit coupling effect.3This is reflected in the turn -off fluorescence response reported in most instances,and the sensors with fluorescence enhancement (turn -on )response are still rare.4Fluorescent probes show fluorescence enhancement on binding to the cation are preferred due to the lower detection limit and high-speed spatial resolution via microscopic imaging.5Therefore,development of fluorescence turn -on type response for monitoring the level of Hg 2+in environmental and biological samples is necessary and indispensable.6Rhodamine-based dyes are used extensively as a fluorescence labeling reagent for their excellent photophysical properties of large absorption coefficients,high fluorescence quantum yields,long absorption and emission wavelength.7When guests interact with the sensors,the spirocyclic form of RhBs is converted to the opened-cyclic form,which changes from colorless and nonfluorescent to pink and strongly fluorescent.Recently,it has been proposed that several rhodamine-based chemosensors acted as turn -on fluorescent sensors for HTM ion.8Although these reported chemosensors have demonstrated reasonable selectivity for HTM ion over other type probes,fluorescent chemosensors of better sensitivity and reactivity for Hg 2+are still required in biological imaging applications.9In the present case,our strategy for designing a multichannel molecular system is combination of the thiospirolacton chro-mophore and the thiophen ring block.The RB-S2receptorCollege of Science and State Key Laboratory of Materials-Oriented Chemical Engineering,Nanjing University of Technology,Nanjing 210009,P .R.China.E-mail:yaochengnjut@;Fax:+86-25-8358-7433;Tel:+86-25-8358-7433†Electronic supplementary information (ESI)available:Experimental procedures,product characterization,copies of 1H NMR and 13C NMR spectra,fluorescence data,and fluorescence spectra.See DOI:10.1039/c0ob00452acontained the thiospirolacton fragment,which is a well-known specific and reversible binding receptor of Hg 2+due to the thiophilic nature of mercury and has been used in a fluorescein-based sensor.Therefore,we speculated that the introduction of the thiophen ring to the thiooxorhodamine-based probe based on the following considerations:(i)increase the affinity to Hg 2+ions in competitive aqueous media;(ii)change the spatial effects within one molecule;(iii)realize the real-time detection (quickly induce the fluorescent and color responses);(iv)improve the sensitivity of Hg 2+ions.In addition,many important sulfur enzymes and electron transfer proteins incorporate a wide range of metals,10which have attracted considerable attention in the synthesis and structural investigations of sulfur-containing chemosensor.The synthesis of RB-S2was shown in Scheme 1.Reaction of Rhodamine B hydrazide with Lawesson’s Reagent in toluene afforded the compound 2with 37%yield.RS-S2was prepared by the condensation of 2-thiophenecarboxaldehyde with 2in MeOH for 12h (71%yield).This Schiff base was stable in EtOH–water solutions and solid state for over 3months.The acid–base titration experiments revealed that RB-S2/RB-S2-Hg 2+remained unaffected between pH 5.58and 9.21(excitation at 515nm)in fluorescence intensity (Figure S1,ESI†),suggesting that it was insensitive to pH near 7.0and could work in approximate physiologicalconditions.Scheme 1Synthesis of rhodamine probe RB-S2.Fig.1shows the fluorescence spectra (l ex =515nm)of probe RB-S2(1m M)in the presence of various metal ions,such as alkali metal ions (K +,Na +),alkali-earth metal ions (Mg 2+,Ca 2+),and heavy/transition metal ions (Fe 2+,Mn 2+,Ni 2+,Co 2+,Cu 2+,Zn 2+,Cd 2+,Ag +,Pb 2+and Cr 3+)in aqueous ethanol (HEPES,50mM,pH 7.0,50:50,v/v).Introduction of Hg 2+to probe RB-S2(1m M)D o w n l o a d e d b y U n i v e r s i t y o f P e n n s y l v a n i a L i b r a r i e s o n 17 S e p t e m b e r 2011P u b l i s h e d o n 22 S e p t e m b e r 2010 o n h t t p ://p u b s .r s c .o r g | d o i :10.1039/C 0O B 00452AFig.1Fluorescence responses of 1m M RB-S2to various 10m M transition-metal ions (1mM for alkali and alkali-earth metal ions).Bars represent the final (F f )over the initial (F i )integrated emission.Spectra were acquired in aqueous ethanol (HEPES,50mM,pH 7.0,50:50,v/v).The red bars represent the addition of the competing metal ion to a 1m M solution of RB-S2.The blue bars represent the change of the emission that occurs upon the subsequent addition of 1m M Hg 2+to the above solution.elicited a large fluorescence enhancement.By contrast,alkali and alkali-earth metal ions even at the mM level had almost no influence.In addition,probe RB-S2only gave a minimal response to transition-metal ions such as Fe 2+,Mn 2+,Ni 2+,Co 2+,Cu 2+,Zn 2+,Cd 2+,Ag +,Pb 2+and Cr 3+in neutral conditions.The competitive experiments were conducted in the presence of 1.0equiv of Hg 2+mixed with 10.0equiv of various cations.No significant variation in fluorescence intensity was found by comparison with Hg 2+ions added in RB-S2solution.Furthermore,the visual response of probe RB-S2to various species demonstrates that the probe can be employed conveniently for Hg 2+detection by simple visual inspection (Figure S5,ESI†).These findings indicated that RB-S2was a Hg 2+-specific fluorescent sensor.In addition,the Na 2S-adding experiments were conducted to examine the reversibility of the RB-S2/Hg 2+species (Figure S4,ESI†).The addition of 0.2ml Na 2S could restore the initial value of free probes due to the K d 10-50M 2value of [HgS 2]2-,the color changed from pink to colorless and the fluorescence was turned off.Thus,the probes could be revived by addition of Hg 2+.Fluorescence titrations of RB-S2with Hg 2+in aqueous ethanol (HEPES,50mM,pH =7.0,50:50,v/v)were performed then.As shown in Fig.2,free probe RB-S2showed almost no fluorescence due to the spirocyclic structure.However,the treatment with Hg 2+induced a dramatic change at 593nm in the fluorescence spectra (442-fold)which was much higher than the result obtained with the early reported rhodamine-based Hg 2+sensors (<200times).11The recognition interaction was completed immediately after the addition of Hg 2+within 1min,compared to its analogues (which needed equilibrium time before detection).12Therefore,RB-S2could be used in real-time determination of Hg 2+in environ-mental and biological conditions.The U.S.EPA (Environmental Protection Agency)standard for the maximum allowable level of inorganic Hg in drinking water is no more than 2ppb.13The Hg 2+interaction with RB-S2at the low concentration region (0.5¥10-8M ~3.14¥10-8M)showed nearly linear relation (Figure S3,ESI†).The I /I o was proportional to the amount of Hg 2+added in ppb level with a detection limit of 1.72¥10-9M.TheassociationFig.2Fluorescence spectra of RB-S2(1m M)in aqueous ethanol (50mM,pH 7.0,50:50,v/v)upon addition of different amounts of Hg 2+ion.Excitation was performed at 515nm.The photograph shows the fluorescent color of RB-S2(1m M)upon addition 2.0equiv Hg 2+in solution.Inset:fluorescence enhancement at 593nm as a function of Hg 2+concentration.constant (K a)of RB-S2with Hg 2+is 1.86¥106M -1obtained by a nonlinear curve fitting of the fluorescence titration results.14The absorption spectra (Fig.3)of RB-S2in 50%EtOH solution exhibited a very weak band above 500nm,which was indicated that the spirolactam RhB form was the predominant species.Upon the addition of 1.5equiv Hg 2+ions,a new strong absorption band centered at 567nm was formed (217-fold)and led to the color change from colorless to pink,suggesting the formation of the spirolactam ring-opened RB-S2.Other metal ions had little interference.Only Ag +ions and Cu 2+ions displayed a 15-fold and 39-fold enhancement at the same concentration (Figure S6,ESI†).Stoichiometry for the complexes formed for Hg 2+ions was evaluated on the basis of the Job’s plot and was found to be 1:1.The corroborative evidence for the 1:1Stoichiometry was confirmed by ESI-MS (Figure S7,ESI†).Fig.3Absorption spectra of 5m M RB-S2in aqueous ethanol (50mM,pH 7.0,50:50,v/v)upon addition of different amounts of Hg 2+ions.Inset:the Job’s plot;the total concentration of ([Hg 2+]+[RB-S2])was 10m M.Without Hg 2+ions,the peak m /z 567.14corresponds to [RB-S2+H]+.When 2.0equiv of Hg 2+was introduced to the RB-S2ethanol solution,a new peak appeared at m /z 867.1and was assigned to single-charged complex [RB-S2+Hg 2++ClO 4-]+(calculated value 867.1).D o w n l o a d e d b y U n i v e r s i t y o f P e n n s y l v a n i a L i b r a r i e s o n 17 S e p t e m b e r 2011P u b l i s h e d o n 22 S e p t e m b e r 2010 o n h t t p ://p u b s .r s c .o r g | d o i :10.1039/C 0O B 00452AWe then tested the ability of RB-S2to track Hg 2+levels in living cells using a model for respiratory Hg 2+exposure (Fig.3).The MCF-7cells (human breast carcinoma cell line)were incubated with RB-S2(5m M)of Hg 2+-AM for up to 0.5h at 37◦C showed very weak negligible intracellular fluorescence (Fig.4b).However,the cells loaded with RB-S2(5m M)displayed a significant red fluorescence from the intracellular area (Fig.4c).Bright-field measurements confirmed that the cells after treatment with Hg 2+and RB-S2were viable throughout the imaging experiments (Fig.4a).The overlay of fluorescence and bright-field images reveals that the fluorescence signals are localized in the perinuclear area of the cytosol (Fig.4f).Furthermore,the fluorescence microscopy images of MCF-7cells contained with RB-S2/Hg 2+and Hoechst 33342(Fig.4d),a well-known fluorescent probe for the cell nucleus,15merged well with the Hg 2+exposure image of perinuclear area (Fig.4g).This result not only indicated that RB-S2had a good cell-membrane permeability,but also revealed that the Hg 2+predominantly existed in the perinucleararea.Fig.4(a)Brightfield image of cells shown in panel.(b)Cells incubated with RB-S2(5m M)in ethanol/PBS (1:49,v/v)buffer for 30min.(c)and then further incubated with 5m M RB-S2for 30min.(d)cell nucleus labeled with Hoechst 33342(1m M).(e)The overlay image of (c)and (d).(f)The overlay image of (a)and (c).In recent years,there are many reports about Hg 2+-induced cell and against Hg 2+-induced cell death applied to cultured cells.16We employed MTT assay to investigate cytotoxicity of Hg 2+and RB-S2to the MCF-7cell lines (Fig.5).The cell viability declined by 79.4%upon Hg 2+(25m M)treatment (24h),while the viability of the Hg 2+-poisoned cell increased by 11.7%with the addition of RB-S2.At the lower concentration (0.2~2m M),the addition of RB-S2did not change the cell viability exposure to Hg 2+-poisoned cells.These cytotoxicity tests suggest that RB-S2may be agoodFig.5Cell viability was quantified by the MTT assay (MCF-7,24h).candidate to reduce the cytotoxicity of Hg 2+due to sulfur atom compatible with the biological system.In summary,we have developed a thiophen-thiooxorhodamine conjugate chemosensor for Hg 2+,which is a dual-responsive col-orimetric and fluorescent Hg 2+-specific sensor in aqueous solution with high selectivity and excellent sensitivity.The significant changes in the fluorescence color could be used for naked-eye detection.Moreover,fluorescence imaging shows RB-S2can be used for low cytotoxicity detecting changes in Hg 2+levels within living cells.The molecular design presented here may contribute to the development of more efficient and more useful chemosensors based on the rhodamine platform.AcknowledgementsThis work is supported by the Open Fund of the State Key Laboratory of Materials-Oriented Chemical Engineering (KL09-9),the postgraduate practice innovation fund of Jiangsu province,and the doctor thesis innovation fund of Nanjing University of Technology.References1(a )C.J.Chang,J.Jaworski,E.M.Nolan,M.Sheng and S.J.Lippard,Proc.Natl.Acad.Sci.U.S.A.,2004,101,1129–1134;(b )H.Komatsu,T.Miki,D.Citterio,T.Kubota,Y .Shindo,Y .Kitamura,K.Oka and K.Suzuki,J.Am.Chem.Soc.,2005,127,10798–10799;(c )G.Farruggia,S.Lotti,M.Montalti,N.Zaccheroni,P .B.Savage,V .Trapani,P .Sale and F .Wolf,J.Am.Chem.Soc.,2006,128,344–350;(d )M.Rosario,C.Matt,M.Stifun and B.Mark,Angew.Chem.,Int.Ed.,2006,45,5472–5474;(e )M.Zhang,M.X.Yu,F .Y .Li,M.W .Zhu,M.Y .Li,Y .H.Gao,L.Li,Z.Q.Liu,J.P .Zhang,D.Q.Zhang,T.Yi and C.H.Huang,J.Am.Chem.Soc.,2007,129,10322–10323.2(a )B.R.Von,J.Appl.Toxicol.,1995,15,483–493;(b )H.H.Harris,I.J.Pickering and G.N.George,Science ,2003,301,1203–1203;(c )E.M.Nolan and S.J Lippard,Chem.Rev.,2008,108,3443–3480.3(a )G.G.Talanova,N.S.A.Elkarim,V .S.Talanov and R.A.Bartsch,Anal.Chem.,1999,71,3106–3109;(b )S.Y .Moon,N.J.Y oun,S.M.Park and S.K.Chang,.Chem.,2005,70,2394–2397;(c )X.J.Zhu,S.T.Fu,W .K.Wong,J.P .Guo and W .Y .Wong,Angew.Chem.,Int.Ed.,2006,45,3150–3154;(d )C.L.He,F .L.Ren,X.B.Zhang and Z.X.Han,Talanta ,2006,70,364–369;(e )M.Suresh,A.Ghosh and A.Das,mun.,2008,3906–3908;(f )X.J.Liu,C.Qi,T.Bing,X.H.Cheng and D.H.Shangguan,Anal.Chem.,2009,81,3699–3704.4(a )X.F .Guo,X.H.Qian and L.H.Jia,J.Am.Chem.Soc.,2004,126,2272–2273;(b )Y .K.Yang,K.J.Y ook and J.Tae,J.Am.Chem.Soc.,2005,127,16760–16761;(c )S.K.Ko,Y .K.Yang,J.Tae and I.Shin,J.Am.Chem.Soc.,2006,128,14150–14155;(d )S.Y oon,E.W .Miller,Q.He,P .H.Do and C.J.Chang,Angew.Chem.,Int.Ed.,2007,46,6658–6661;(e )B.Tang,L.J.Cui and K.H.Xu,Chembiochem.,2008,9,1159–1164.5(a )M.Suresh,A.Shrivastav,S.Mishra,E.Suresh and A.Das,Org.Lett.,2008,10,3013–3016;(b )N.C.Lim,H.C.Freake and C.Bruckner,Chem.–Eur.J.,2005,11,38–49;(c )D.Yang,H.L.Wang,Z.N.Sun,N.W .Chung and J.G.Shen,J.Am.Chem.Soc.,2006,128,6004–6005.6(a )H.N.Kim,M.H.Lee,H.J.Kim and J.S.Kim,Chem.Soc.Rev.,2008,37,1465–1472;(b )M.Beija,C.A.M.Afonso and J.M.G.Martinho,Chem.Soc.Rev.,2009,38,2410–2433.kowicz,Principles,of Fluorescence Spectroscopy ,3rd ed.;Springer:New Y ork,2006,pp 67–69.8(a )Y .Xiang,A.Tong,P .Jin and Y .Ju,Org.Lett.,2006,8,2863–2866;(b )H.Zheng,Z.H.Qian,L.Xu,F .F .Yuan,n and J.G.Xu,Org.Lett.,2006,8,859–861;(c )M.H.Lee,J.S.Wu,J.W .Lee,J.H.Jung and J.S.Kim,Org.Lett.,2007,9,2501–2504;(d )H.Yang,Z.Zhou,K.Huang,M.Yu,F .Li,T.Yi and C.Huang,Org.Lett.,2007,9,4729–4732;(e )D.Wu,W .Huang,C.Duan,Z.Lin and Q.Meng,Inorg.Chem.,2007,46,1538–1540;(f )Y .Shiraishi,S.Sumiya,Y .Kohno and T.Hirai,.Chem.,2008,73,8571–8574;(g )M.Suresh,S.Mishra,S.K.Mishra,E.Suresh,A.K.Mandal,A.Shrivastav and A.Das,Org.D o w n l o a d e d b y U n i v e r s i t y o f P e n n s y l v a n i a L i b r a r i e s o n 17 S e p t e m b e r 2011P u b l i s h e d o n 22 S e p t e m b e r 2010 o n h t t p ://p u b s .r s c .o r g | d o i :10.1039/C 0O B 00452ALett.,2009,11,2740–2743;(h )J.Huang,Y .Xu and X.Qian,.Chem.,2009,74,2167–2170;(i )M.H.Lee,T.V .Giap,S.H.Kim,Y .H.Lee,C.Kang and J.S.Kim,mun.,2010,46,1407–1409.9(a )M.Santra,D.Ryu,A.Chatterjee,S.K.Ko,I.Shin and K.H.Ahn,mun.,2009,2115–2117;(b )C.S.Lim,D.W .Kang,Y .S.Tian,J.H.Han,H.L.Hwang and B.R.Cho,mun.,2010,46,2388–2390;(c )J.Du,J.Fan,X.Peng,P .Sun,J.Wang,H.Li and S.Sun,Org.Lett.,2010,12,476–479.10(a )K.Matsumoto and Y .Y .Sano,Inorg.Chem.,1997,36,4405–4407;(b )Y .Zhang,J.L.Zuo,H.C.Zhou and R.H.Holm,J.Am.Chem.Soc.,2002,124,14292–14293;(c )G.Henkel and B.Krebs,Chem.Rev.,2004,104,801–824.11J.H.Soh,K.M.K.Swamy,S.K.Kim,S.Kim,S.H.Lee and J.Y oon,Tetrahedron Lett.,2007,48,5966–5969.12M.Yu,M.Shi,Z.Chen,F .Li,X.Li,Y .Gao,J.Xu,H.Yang,Z.Zhou,T.Yi and C.Huang,Chem.–Eur.J.,2008,14,6892–6900.13Mercury Update:Impact on Fish Advisories.EPA Fact Sheet EPA -823-F -01-011;EPA,Office of Water:Washington,DC,2001.14(a )K.A.Conners,Binding,Constants ;Wiley:New Y ork,1987;(b )B.Valeur Molecular,Fluorescence.Principles and Applications ;Wiley-VCH:Weinheim,2002.15(a )A Guide to Fluorescent Probes and Labeling Technologies ,10th ed.;R.P .Haugland,Ed.;Molecular Probes:Eugene,OR,2005;(b )J.H.Lee,C.S.Lim,Y .S.Tian,J.H.Han and B.R.Cho,J.Am.Chem.Soc.,2010,132,1216–1217.16(a )K.Cederbrant and P .Hultman,Clin.Exp.Immunol.,2000,121,23–30;(b )P .L.Goering,B.R.Fisher,B.T.Noren,A.Papaconstantinou,J.L.Rojko and R.J.Marler,Toxicol.Sci.,2000,53,447–457;(c )sh,D.A.Putt and R.K.Zalups,Toxicol.Sci.,2005,88,630–644;(d )J.Heo,Cell Biochemistry and Biophysics ,2008,51,21–32.D o w n l o a d e d b y U n i v e r s i t y o f P e n n s y l v a n i a L i b r a r i e s o n 17 S e p t e m b e r 2011P u b l i s h e d o n 22 S e p t e m b e r 2010 o n h t t p ://p u b s .r s c .o r g | d o i :10.1039/C 0O B 00452A。

相关文档
最新文档